HOXB7 and head and neck squamous cell carcinoma: Overall, our results revealed critical involvement of HOXB7 in HNSCC tumorigenesis and suggested that HOXB7 could be used as a novel prognostic biomarker and a potential therapeutic target for HNSCC.